These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21916093)

  • 1. [Withdrawing of IVIG compound from the market].
    Shoenfeld Y
    Harefuah; 2010 Dec; 149(12):754-5. PubMed ID: 21916093
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemolysis upon intravenous immunoglobulin transfusion.
    Padmore RF
    Transfus Apher Sci; 2012 Feb; 46(1):93-6. PubMed ID: 22169381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriate use of intravenous immunoglobulin in neonatal neutropenia.
    Buenz EJ; Howe CL
    J Perinatol; 2007 Mar; 27(3):196-7; author reply 197. PubMed ID: 17314992
    [No Abstract]   [Full Text] [Related]  

  • 4. Giving intravenous immunoglobulin.
    Scherf R; White-Reid K
    RN; 2008 Jan; 71(1):29-34; quiz 35. PubMed ID: 18271361
    [No Abstract]   [Full Text] [Related]  

  • 5. Vesicular eczema after intravenous immunoglobulin therapy for treatment of Stevens-Johnson syndrome.
    Young PK; Ruggeri SY; Galbraith S; Drolet BA
    Arch Dermatol; 2006 Feb; 142(2):247-8. PubMed ID: 16490861
    [No Abstract]   [Full Text] [Related]  

  • 6. Impairment of renal function after intravenous immunoglobulin.
    Soares SM; Sethi S
    Nephrol Dial Transplant; 2006 Mar; 21(3):816-7. PubMed ID: 16399766
    [No Abstract]   [Full Text] [Related]  

  • 7. [The new domestic immunoglobulin G gabriglobin in complex therapy of immunodeficiency states and infectious pathology].
    Pas'ko VG; Latysheva TV; Nikiforov VV; Mostovskaia EV; Denisov AK; Kondrashin IuI
    Voen Med Zh; 2006 Jul; 327(7):40-2. PubMed ID: 16977880
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous immunoglobulin-induced, non-eczematous, vesiculobullous eruptions in Stevens-Johnson syndrome.
    Lin WL; Lin WC; Chang YC; Yang LC; Hung SI; Hong HS; Chung WH
    Am J Clin Dermatol; 2009; 10(5):339-42. PubMed ID: 19658448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editors' Notes.
    Klein HG; Schreiber GB
    Transfusion; 2015 Jul; 55 Suppl 2():S1. PubMed ID: 26174886
    [No Abstract]   [Full Text] [Related]  

  • 10. IVIG-triggered tubulointerstitial nephritis in X-linked agammaglobulinemia.
    Takeguchi M; Korematsu S; Miyahara H; Kuga S; Izumi T
    Pediatr Int; 2017 Aug; 59(8):945-946. PubMed ID: 28707726
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemolytic adverse events with immune globulin products: product factors and patient risks.
    Scott DE; Epstein JS
    Transfusion; 2015 Jul; 55 Suppl 2():S2-5. PubMed ID: 26174893
    [No Abstract]   [Full Text] [Related]  

  • 12. Proposed relationship between intravenous immunoglobulin and thrombosis in renal transplant recipients.
    Duronio A; Bajjoka I; Hsaiky L; Parasuraman R
    Ann Pharmacother; 2007 Feb; 41(2):354-8. PubMed ID: 17264157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human intravenous immunoglobulin-induced aseptic meningitis: a case report.
    Chaabane A; Hamzaoui A; Aouam K; Klai R; Fredj NB; Boughattas NA; Mahjoub S
    J Clin Pharmacol; 2012 Feb; 52(2):279-81. PubMed ID: 21257801
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of hypogammagammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation.
    Ankersmit HJ; Hacker S; Hoetzenecker K; Moser B; Wolner E
    J Heart Lung Transplant; 2006 Nov; 25(11):1387-8. PubMed ID: 17097508
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe eczematous skin reaction after high-dose intravenous immunoglobulin infusion: report of 4 cases and review of the literature.
    Vecchietti G; Kerl K; Prins C; Kaya G; Saurat JH; French LE
    Arch Dermatol; 2006 Feb; 142(2):213-7. PubMed ID: 16490849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of inflammation in intravenous immune globulin-mediated hemolysis.
    Pendergrast J; Willie-Ramharack K; Sampson L; Laroche V; Branch DR
    Transfusion; 2015 Jul; 55 Suppl 2():S65-73. PubMed ID: 26174900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin therapy for neuromuscular disorders.
    Ross MA
    Semin Neurol; 2007 Sep; 27(4):340-6. PubMed ID: 17701871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients.
    Billing H; Rieger S; Ovens J; Süsal C; Melk A; Waldherr R; Opelz G; Tönshoff B
    Transplantation; 2008 Nov; 86(9):1214-21. PubMed ID: 19005402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin: adverse reactions and management.
    Bonilla FA
    J Allergy Clin Immunol; 2008 Dec; 122(6):1238-9. PubMed ID: 18842292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.